INS and type 2 diabetes mellitus: In patients with type 2 diabetes, over 29 days, body weight was reduced by up to 3 kg, fasting plasma glucose was reduced by up to 3 mmol/l, plasma glucose following an oral glucose load was dose-dependently reduced, while insulin secretory responses were dose-dependently increased.